BACKGROUND AND PURPOSE: Three-dimensional imaging and hemispheric volumetry are useful for the assessment of degenerative cortical atrophy. Our purpose was to determine the features of cortical atrophy in progressive supranuclear palsy (PSP) and corticobasal degen-eration (CBD) by means of a hemispheric surface display generated with MR images. METHODS: The extent of cortical atrophy was evaluated with automated MR hemispheric surface display and volumetry in 19 patients with PSP and 19 with CBD. RESULTS: Most cortical regions were less atrophic in PSP than in CBD. The parietal lobe, paracentral regions, anterior middle frontal lobe, and posterior inferior frontal lobe were significantly more atrophic in CBD than in PSP, whereas the brainst...
Parkinson's disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) are...
We report an interesting case demonstrating co-occurrence of radiological features of progressive s...
Posterior Cortical Atrophy (PCA) is a neurodegenerative disease characterized by a progressive decli...
Purpose: Diagnosing corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) is ofte...
AbstractPurposeDiagnosing corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) i...
peer reviewedThis report emphasizes the precise topographic distribution of cerebral metabolic impai...
This report emphasizes the precise topographic distribution of cerebral metabolic impairment in cort...
distribution of cerebral metabolic impairment in corticobasal degeneration (CBD) and the pathophysio...
Objective: Parkinson’s disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Pals...
BACKGROUND AND PURPOSE: Quantitative evaluation of midbrain atrophy may be useful in differentiating...
Parkinson's disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) are...
Objectives - To assess midbrain atrophy through morphometric (linear, surface and volumetric) measur...
IntroductionThere are no effective treatments for progressive supranuclear palsy (PSP). Volumetric M...
IntroductionThere are no effective treatments for progressive supranuclear palsy (PSP). Volumetric M...
The aim of this study was to correlate neuropsychological and neuroimaging findings in corticobasal ...
Parkinson's disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) are...
We report an interesting case demonstrating co-occurrence of radiological features of progressive s...
Posterior Cortical Atrophy (PCA) is a neurodegenerative disease characterized by a progressive decli...
Purpose: Diagnosing corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) is ofte...
AbstractPurposeDiagnosing corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) i...
peer reviewedThis report emphasizes the precise topographic distribution of cerebral metabolic impai...
This report emphasizes the precise topographic distribution of cerebral metabolic impairment in cort...
distribution of cerebral metabolic impairment in corticobasal degeneration (CBD) and the pathophysio...
Objective: Parkinson’s disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Pals...
BACKGROUND AND PURPOSE: Quantitative evaluation of midbrain atrophy may be useful in differentiating...
Parkinson's disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) are...
Objectives - To assess midbrain atrophy through morphometric (linear, surface and volumetric) measur...
IntroductionThere are no effective treatments for progressive supranuclear palsy (PSP). Volumetric M...
IntroductionThere are no effective treatments for progressive supranuclear palsy (PSP). Volumetric M...
The aim of this study was to correlate neuropsychological and neuroimaging findings in corticobasal ...
Parkinson's disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) are...
We report an interesting case demonstrating co-occurrence of radiological features of progressive s...
Posterior Cortical Atrophy (PCA) is a neurodegenerative disease characterized by a progressive decli...